In situ forming chitosan hydrogels prepared via ionic/covalent co-cross-linking.

In situ forming chitosan hydrogels have been prepared via coupled ionic and covalent cross-linking. Thus, different amounts of genipin (0.05, 0.10, 0.15, and 0.20% (w/w)), used as a chemical cross-linker, were added to a solution of chitosan that was previously neutralized with a glycerol-phosphate complex (ionic cross-linker). In this way, it was possible to overcome the pH barrier of the chitosan solution, to preserve its thermosensitive character, and to enhance the extent of cross-linking in the matrix simultaneously. To investigate the contributions of the ionic cross-linking and the chemical cross-linking, separately, we prepared the hydrogels without the addition of either genipin or the glycerol-phosphate complex. The addition of genipin to the neutralized solution disturbs the ionic cross-linking process and the chemical cross-linking becomes the dominant process. Moreover, the genipin concentration was used to modulate the network structure and performance. The more promising formulations were fully characterized, in a hydrated state, with respect to any equilibrium swelling, the development of internal structure, the occurrence of in vitro degradability and cytotoxicity, and the creation of in vivo injectability. Each of the hydrogel systems exhibited a notably high equilibrium water content, arising from the fact that their internal structure (examined by conventional SEM, and environmental SEM) was highly porous with interconnecting pores. The porosity and the pore size distribution were quantified by mercury intrusion porosimetry. Although all gels became degraded in the presence of lysozyme, their degradation rate greatly depended on the genipin load. Through in vitro viability tests, the hydrogel-based formulations were shown to be nontoxic. The in vivo injection of a co-cross-linking formulation revealed that the gel was rapidly formed and localized at the injection site, remaining in position for at least 1 week.

[1]  J. Viyoch,et al.  Properties of β-glycerol phosphate/collagen/chitosan blend scaffolds for application in skin tissue engineering , 2009 .

[2]  N. Peppas,et al.  Structure and Interactions in Covalently and Ionically Crosslinked Chitosan Hydrogels for Biomedical Applications , 2003 .

[3]  A Hatefi,et al.  Biodegradable injectable in situ forming drug delivery systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[4]  J. Brouwer,et al.  Determination of lysozyme in serum, urine, cerebrospinal fluid and feces by enzyme immunoassay. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[5]  J. Ong,et al.  The effect of cross-linking of chitosan microspheres with genipin on protein release , 2007 .

[6]  M. Shive,et al.  Ultrastructure of hybrid chitosan–glycerol phosphate blood clots by environmental scanning electron microscopy , 2008, Microscopy research and technique.

[7]  H. Sung,et al.  Synthesis and characterization of biodegradable TPP/genipin co-crosslinked chitosan gel beads , 2003 .

[8]  J. D. de Bruijn,et al.  Biocompatibility and gelation of chitosan-glycerol phosphate hydrogels. , 2008, Journal of biomedical materials research. Part A.

[9]  Ho-Suk Choi,et al.  Preparation and biodegradation of thermosensitive chitosan hydrogel as a function of pH and temperature , 2004 .

[10]  British Standard,et al.  Biological evaluation of medical devices , 2006 .

[11]  A. Jayakrishnan,et al.  Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds. , 2005, Biomaterials.

[12]  P. Pudney,et al.  Mechanism and kinetics of the crosslinking reaction between biopolymers containing primary amine groups and genipin , 2003 .

[13]  J. Leroux,et al.  Novel injectable neutral solutions of chitosan form biodegradable gels in situ. , 2000, Biomaterials.

[14]  M. Shoichet,et al.  Controlling cell adhesion and degradation of chitosan films by N-acetylation. , 2005, Biomaterials.

[15]  K. Shakesheff,et al.  Injectable scaffolds for tissue regeneration , 2004 .

[16]  A. Ghanem,et al.  Fabrication and characterization of DTBP-crosslinked chitosan scaffolds for skin tissue engineering. , 2005, Biomaterials.

[17]  M. H. Gil,et al.  Rheological study of genipin cross-linked chitosan hydrogels. , 2007, Biomacromolecules.

[18]  Miqin Zhang,et al.  Chitosan-based hydrogels for controlled, localized drug delivery. , 2010, Advanced drug delivery reviews.

[19]  C. Dass,et al.  Injectable chitosan hydrogels for localised cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Jia-cong Shen,et al.  Covalently crosslinked chitosan hydrogel formed at neutral pH and body temperature. , 2006, Journal of biomedical materials research. Part A.

[21]  H. Sung,et al.  In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. , 1999, Journal of biomaterials science. Polymer edition.

[22]  R. Snyders,et al.  Mechanical and microstructural properties of hybrid poly(ethylene glycol)-soy protein hydrogels for wound dressing applications. , 2007, Journal of biomedical materials research. Part A.

[23]  H. Sung,et al.  In vitro evaluation of a chitosan membrane cross-linked with genipin , 2001, Journal of biomaterials science. Polymer edition.

[24]  J. Leroux,et al.  Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. , 2000, International journal of pharmaceutics.

[25]  Yi Hong,et al.  Covalently crosslinked chitosan hydrogel: properties of in vitro degradation and chondrocyte encapsulation. , 2007, Acta biomaterialia.

[26]  F. Mi,et al.  Characterization of ring‐opening polymerization of genipin and pH‐dependent cross‐linking reactions between chitosan and genipin , 2005 .

[27]  M. H. Gil,et al.  Rheology of Chitosan and Genipin Solutions , 2008 .

[28]  H. Sung,et al.  Synthesis and characterization of a novel chitosan‐based network prepared using naturally occurring crosslinker , 2000 .

[29]  F. Mi,et al.  Chitosan–polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. II. Effect of pH-dependent ionic crosslinking or interpolymer complex using tripolyphosphate or polyphosphate as reagent , 1999 .

[30]  J. Feijen,et al.  Injectable chitosan-based hydrogels for cartilage tissue engineering. , 2009, Biomaterials.

[31]  H. Faneca,et al.  Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.